Activist 13D/13G Filings - COLUMN GROUP L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-04-05
10:55 am
Sale		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P1,000
100.000%		-22,078,509decrease
(-100.00%)		View
2024-02-26
5:16 pm
Unchanged		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P22,079,509
26.700%		0
(Unchanged)		View
2023-12-29
4:05 pm
Purchase		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P22,079,509
26.700%		1,094,533increase
(+5.22%)		View
2022-06-10
4:14 pm
Purchase		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P20,984,976
26.500%		1,951,343increase
(+10.25%)		View
2022-02-11
4:34 pm
Sale		13GNurix Therapeutics Inc.
NRIX		COLUMN GROUP L P654,245
1.500%		-6,101,636decrease
(-90.32%)		View
2022-02-03
5:23 pm
Purchase		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P19,033,633
24.500%		1,378,422increase
(+7.81%)		View
2021-02-12
6:16 pm
Purchase		13GNurix Therapeutics Inc.
NRIX		COLUMN GROUP L P6,755,881
17.400%		6,755,881increase
(New Position)		View
2021-02-12
6:14 pm
Unchanged		13GCONSTELLATION PHARMACEUTICALS INC
CNST		COLUMN GROUP L P6,240,638
13.100%		0
(Unchanged)		View
2020-06-24
4:15 pm
Purchase		13GCONSTELLATION PHARMACEUTICALS INC
CNST		COLUMN GROUP L P6,240,638
13.100%		41,674increase
(+0.67%)		View
2020-04-02
06:07 am
Purchase		13DNGM BIOPHARMACEUTICALS INC
NGM		COLUMN GROUP L P17,655,211
26.000%		1,111,314increase
(+6.72%)		View